The one that got me was the 30th Sept announcement and more precisely this part of the announcement
Initial sales of Ropren® in countries outside Russia have commenced with prices realised at
or above a baseline level of $3,000 for a standard three month course. Volume sales in
Russia are expected to commence within weeks.
People are starting to believe but lets not get to excited just yet.
shareholder resolve, page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)